1. Focus on the prophylaxis, epidemiology and therapy of methicillin-resistant Staphylococcus aureus surgical site infections and a position paper on associated risk factors: the perspective of an Italian group of surgeons.
- Author
-
Sganga, G., Tascini, C., Sozio, E., Carlini, M., Chirletti, P., Cortese, F., Gattuso, R., Granone, P., Pempinello, C., Sartelli, M., and Colizza, S.
- Subjects
- *
SURGICAL site infection prevention , *ANTIBIOTICS , *AGE distribution , *CEPHALOSPORINS , *THORACIC surgery , *DELPHI method , *HOSPITAL care , *LENGTH of stay in hospitals , *LAPAROSCOPIC surgery , *OBSTRUCTIVE lung diseases , *NURSING home patients , *PUBLIC health surveillance , *QUINOLONE antibacterial agents , *SURGICAL site infections , *TIME , *SYSTEMATIC reviews , *CARBAPENEMS , *METHICILLIN-resistant staphylococcus aureus , *ANTIBIOTIC prophylaxis , *DISEASE risk factors - Abstract
Background: The aim of this research was to study the epidemiology, microbiology, prophylaxis, and antibiotic therapy of surgical site infections (SSIs), especially those caused by methicillin-resistant Staphylococcus aureus (MRSA), and identify the risk factors for these infections. In Italy SSIs occur in about 5 % of all surgical procedures. They are predominantly caused by staphylococci, and 30 % of them are diagnosed after discharge. In every surgical specialty there are specific procedures more associated with SSIs. Methods: The authors conducted a systematic review of the literature on SSIs, especially MRSA infections, and used the Delphi method to identify risk factors for these resistant infections. Results: Risk factors associated with MRSA SSIs identified by the Delphi method were: patients from long-term care facilities, recent hospitalization (within the preceding 30 days), Charlson score > 5 points, chronic obstructive pulmonary disease and thoracic surgery, antibiotic therapy with beta-lactams (especially cephalosporins and carbapenem) and/or quinolones in the preceding 30 days, age 75 years or older, current duration of hospitalization >16 days, and surgery with prothesis implantation. Protective factors were adequate antibiotic prophylaxis, laparoscopic surgery and the presence of an active, in-hospital surveillance program for the control of infections. MRSA therapy, especially with agents that enable the patient's rapid discharge from hospital is described. Conclusion: The prevention, identification and treatment of SSIs, especially those caused by MRSA, should be implemented in surgical units in order to improve clinical and economic outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF